Perspective Therapeutics CATX
NYSE CATX
$2.67 +0.06 (+2.10%)
As of: Sep 30, 2026 · 2:18 PM EDT

Perspective Therapeutics (CATX) Total Non-Current Liabilities (2011 - 2026)

Updated

Perspective Therapeutics' Total Non-Current Liabilities came in at $67.66 million for Q2 2026, up 51.2% from $44.75 million a year earlier and up 7.6% from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025, Perspective Therapeutics' Total Non-Current Liabilities was $59.56 million, up 18.2% from FY2024.

  • Total Non-Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 90.1% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $50.38 million in FY2024 (+121.8%), $22.71 million in FY2023 (+713.5%), $2.79 million in FY2022 and $2.4 million in FY2021 (+0.1%).
  • The Q2 2026 figure represents the highest quarterly Total Non-Current Liabilities in data going back to Q4 2022.
  • Year-over-year, Total Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 97.3% over the last seven quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q4 2023 (growth of 713.5%), and the weakest in Q3 2025 (a decline of 16.6%).
  • Business Quant data shows CATX's Total Non-Current Liabilities at $62.89 million (Q1 2026), $59.56 million (Q4 2025) and $52.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Perspective Therapeutics 298.91 Mn 298.91 Mn - 67.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.66 Mn
Mar 31, 2026 62.89 Mn
Dec 31, 2025 59.56 Mn
Sep 30, 2025 52.27 Mn
Jun 30, 2025 44.75 Mn
Mar 31, 2025 44.56 Mn
Dec 31, 2024 50.38 Mn
Sep 30, 2024 62.65 Mn
Jun 30, 2024 44.90 Mn
Dec 31, 2023 22.71 Mn
Sep 30, 2023 11.08 Mn
Jun 30, 2023 10.83 Mn
Mar 31, 2023 8.95 Mn
Dec 31, 2022 2.79 Mn
Sep 30, 2022 4.19 Mn
Jun 30, 2022 2.52 Mn
Mar 31, 2022 2.28 Mn
Dec 31, 2021 2.24 Mn
Sep 30, 2021 2.34 Mn
Jun 30, 2021 2.40 Mn
API Access

Perspective Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CATX&period=max&api_key=YOUR_API_KEY